Alvotech has developed a biosimilar of Humira called AVT02, the first-filed biosimilar drug equal in strength to Humira’s latest formulation, which AbbVie markets as a high-concentration, pain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback